Online monitoring of metabolism and morphology of peptide-treated neuroblastoma cancer cells and keratinocytes

Journal of Bioenergetics and Biomembranes

Volumn 43, Issue 3, 2011, Pages 275-285

  Drechsler, Sabine ^b   Andrä, Jörg ^a  

^a RESEARCH CENTER BORSTEL   (Germany)

^b Bionas GmbH   (Germany)

Author keywords

Antimicrobial peptide; Biosensor; Cancer; Glycolysis; HaCaT; Impedance; Keratinocytes; Membrane permeabilization; Neuroblastoma; Respiration

Indexed keywords

MELITTIN; NK 2 PEPTIDE; NK11 PEPTIDE; OXYGEN; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG;

ARTICLE; BIOSENSOR; CELL ADHESION; CELL DAMAGE; CELL METABOLISM; CELL RESPIRATION; CELL STRUCTURE; CELL SURFACE; CELLULAR STRESS RESPONSE; CONTROLLED STUDY; ENERGY METABOLISM; GLYCOLYSIS; HUMAN; HUMAN CELL; KERATINOCYTE; NEUROBLASTOMA CELL; OXYGEN CONSUMPTION; PERFUSION;

CELL LINE; CELL LINE, TUMOR; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; KERATINOCYTES; MELITTEN; NEUROBLASTOMA; PEPTIDES;

EID: 79959745959     PISSN: 0145479X     EISSN: 15736881     Source Type: Journal    
DOI: 10.1007/s10863-011-9350-y     Document Type: Article

References (47)

1. Abarzua S, Drechsler S, Fischer K, Pietschmann N, Stapel J, Duda S, Richter DU, Ehret R, Piechulla B, Briese V (2010) Online monitoring of cellular metabolism in the MCF-7 carcinoma cell line treated with phytoestrogen extracts. Anticancer Res 30:1587-1592
2. Andjelkovic T, Pesic M, Bankovic J, Tanic N, Markovic ID, Ruzdijic S (2008) Synergistic effects of the purine analog sulfinosine and curcumin on the multidrug resistant human non-small cell lung carcinoma cell line (NCI-H460/R). Cancer Biol Ther 7:1024-1032
3. Andrä J, Leippe M (1999) Candidacidal activity of shortened synthetic analogs of amoebapores and NK-lysin. Med Microbiol Immunol 188:117-124 (Pubitemid 30085357)
4. Andrä J, Koch MHJ, Bartels R, Brandenburg K (2004) Biophysical characterization of the endotoxin inactivation by NK-2, an antimicrobial peptide derived from mammalian NK-Lysin. Antimicrob Agents Chemother 48:1593-1599 (Pubitemid 38544364)
5. Andrä J, Monreal D, Martinez de Tejada G, Olak C, Brezesinski G, Sanchez Gomez S, Goldmann T, Bartels R, Brandenburg K, Moriyon I (2007) Rationale for the design of shortened derivatives of the NK-lysin derived antimicrobial peptide NK-2 with improved activity against Gram-negative pathogens. J Biol Chem 282:14719-14728 (Pubitemid 47093359)
6. Baker MA, Maloy WL, Zasloff M, Jacob LS (1993) Anticancer efficacy of magainin 2 and analogue peptides. Cancer Res 53:3052-3057
7. Bechinger B, Lohner K (2006) Detergent-like actions of linear amphipathic cationic antimicrobial peptides. Biochim Biophys Acta 1758:1529-1539 (Pubitemid 44436087)
8. Benachir T, Lafleur M (1995) Study of vesicle leakage induced by melittin. Biochim Biophys Acta 1235:452-460
9. Blondelle SE, Houghten RA (1991) Hemolytic and antimicrobial activities of the twenty-four individual omission analogous of melittin. Biochemistry 30:4671-4678
10. Bodek G, Vierre S, Rivero-Müller A, Huhtaniemi I, Ziecik AJ, Rahman NA (2005) A novel targeted therapy of Leydig and granulosa cell tumors through the luteinizing hormone receptor using a hecate-chorionic gonatropin b conjugate in transgenic mice. Neoplasia 7:497-508 (Pubitemid 40791868)
11. Boukamp P, Petrussevska RT, Breitkreutz D, Hornung J, Markham A, Fusenig NE (1988) Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 106:761-771 (Pubitemid 18089976)
12. Ceriotti L, Kob A, Drechsler S, Ponti J, Thedinga E, Colpo P, Ehret R, Rossi F (2007) Online monitoring of BALB/3 T3 metabolism and adhesion with multiparametric chip-based system. Anal Biochem 371:92-104 (Pubitemid 47538483)
13. Chen YQ, Min C, Sang M, Han YY, Ma X, Xue XQ, Zhang SQ (2010) A cationic amphiphilic peptide ABP-CM4 exhibits selective cytotoxicity against leukemia cells. Peptides 31:1504-1510
14. Chuang CM, Monie A, Wu A, Mao CP, Hung CF (2008) Treatment with LL-37 peptide enhances the antitumor effects induced by CpG oligodeoxynucleotides against ovarian cancer. Hum Gene Ther
15. Cruciani RA, Barker JL, Zasloff M, Chen HC, Colamonici O (1991) Antibiotic magainins exert cytolytic activity against transformed cell lines through channel formation. Proc Natl Acad Sci USA 88:3792-3796 (Pubitemid 21916710)
16. Dempsey CE (1990) The action of melittin on membranes. Biochim Biophys Acta 1031:143-161
17. Eisenberg D, Schwarz E, Komaroy M, Wall R (1984) Analysis of membrane and surface protein sequences with the hydrophobic moment plot. J Mol Biol 179:125-142 (Pubitemid 16223392)
18. Habermann E, Jentsch J (1967) Sequenzanalyse des Melittins aus den tryptischen und peptischen Spaltstücken. Hoppe-Seyleŕs Z Physiol Chem 351:884-890
19. Hammer M, Brauser A, Olak C, Brezesinski G, Goldmann T, Gutsmann T, Andrä J (2010) Lipopolysaccharide interaction is decisive for the activity of the antimicrobial peptide NK-2 against Escherichia coli and Proteus mirabilis. Biochem J 427:477-488
20. Harder J, Bartels J, Christophers E, Schröder JM (1997) A peptide antibiotic from human skin. Nature 387:861
21. Harder J, Bartels J, Christophers E, Schröder JM (2001) Isolation and characterization of human beta-defensin-3, a novel human inducible peptide antibiotic. J Biol Chem 276:5707-5713
22. Hoskin DW, Ramamoorthy A (2008) Studies on anticancer activities of antimicrobial peptides. Biochim Biophys Acta 1778:357-375
23. Hui L, Leung K, Chen HM (2002) The combined effects of antibacterial peptide cecropin A and anti-cancer agents on leukemia cells. Anticancer Res 22:2811-2816 (Pubitemid 36069317)
24. Jenssen H, Hamill P, Hancock RE (2006) Peptide antimicrobial agents. Clin Microbiol Rev 19:491-511 (Pubitemid 44137212)
25. Johnstone SA, Gelmon K, Mayer LD, Hancock RE, Bally MB (2000) In vitro characterization of the anticancer activity of membrane-active cationic peptides. I. Peptide-mediated cytotoxicity and peptide-enhanced cytotoxic activity of doxorubicin against wild-type and p-glycoprotein over-expressing tumor cell lines. Anti-canc Drug Des 15:151-160
26. Kim S, Kim SS, Bang YJ, Kim SJ, Lee BJ (2003) In vitro activities of native and designed peptide antibiotics against drug sensitive and resistant tumor cell lines. Peptides 24:945-953
27. Kyte J, Doolittle RF (1982) A simple method for displaying the hydropathic character of a protein. J Mol Biol 157:105-132
28. Larrick JW, Hirata M, Zhong J, Wright SC (1995) Anti-microbial activity of human CAP18 peptides. Immunotechnology 1:65-72
29. Leippe M, Andrä J, Müller-Eberhard HJ (1994) Cytolytic and antibacterial activity of synthetic peptides derived from amoebapore, the pore-forming peptide of Entamoeba histolytica. Proc Natl Acad Sci USA 91:2602-2606 (Pubitemid 24139395)
30. Makovitzki A, Fink A, Shai Y (2009) Suppression of human solid tumor growth in mice by intratumor and systemic inoculation of histidine-rich and pH-dependent host defense-like lytic peptides. Cancer Res 69:3458-3463
31. Matsuzaki K, Sugishita K, Fujii N, Miyajima K (1995) Molecular basis for membrane selectivity of an antimicrobial peptide, magainin 2. Biochemistry 34:3423-3429
32. Ohsaki Y, Gazdar AF, Chen HC, Johnson BE (1992) Antitumor activity of magainin analogues against human lung cancer cell lines. Cancer Res 52:3534-3538
33. Papo N, Braunstein A, Eshhar Z, Shai Y (2004) Suppression of human prostate tumor growth in mice by a cytolytic D-, L-amino Acid Peptide: membrane lysis, increased necrosis, and inhibition of prostate-specific antigen secretion. Cancer Res 64:5779-5786 (Pubitemid 39095578)
34. Papo N, Seger D, Makovitzki A, Kalchenko V, Eshhar Z, Degani H, Shai Y (2006) Inhibition of tumor growth and elimination of multiple metastases in human prostate and breast xenografts by systemic inoculation of a host defense-like lytic peptide. Cancer Res 66:5371-5378 (Pubitemid 43844963)
35. Russell PJ, Hewish D, Carter T, Sterling-Levis K, Ow K, Hattarki M, Doughty L, Guthrie R, Shapira D, Molloy PL, Werkmeister JA, Kortt AA (2004) Cytotoxic properties of immunoconjugates containing melittin-like peptide 101 against prostate cancer: in vitro and in vivo studies. Cancer Immunol Immunother 53:411-421 (Pubitemid 38657254)
36. Schröder-Borm H, Willumeit R, Brandenburg K, Andrä J (2003) Molecular basis for membrane selectivity of NK-2, a potent peptide antibiotic derived from NK-lysin. Biochim Biophys Acta 1612:164-171
37. Schröder-Borm H, Bakalova R, Andrä J (2005) The NK-lysin derived peptide NK-2 preferentially kills cancer cells with increased surface levels of negatively charged phosphatidylserine. FEBS Lett 579:6128-6134
38. Schweizer F (2009) Cationic amphiphilic peptides with cancer-selective toxicity. Eur J Pharmacol 625:190-194
39. Stortecky S, Suter TM (2010) Insights into cardiovascular side-effects of modern anticancer therapeutics. Curr Opin Oncol 22:312-317
40. Tang C, Shao X, Sun B, Huang W, Qiu F, Chen Y, Shi YK, Zhang EY, Wang C, Zhao X (2010) Anticancer mechanism of peptide P18 in human leukemia K562 cells. Org Biomol Chem 8:984-987
41. Thedinga E, Kob A, Holst H, Keuer A, Drechsler S, Niendorf R, Baumann W, Freund I, Lehmann M, Ehret R (2007) Online monitoring of cell metabolism for studying pharmacodynamic effects. Toxicol Appl Pharmacol 220:33-44 (Pubitemid 46427860)
42. Wang KR, Yan JX, Zhang BZ, Song JJ, Jia PF, Wang R (2009) Novel mode of action of polybia-MPI, a novel antimicrobial peptide, in multi-drug resistant leukemic cells. Cancer Lett 278:65-72
43. Warren P, Li L, Song W, Holle E, Wei Y, Wagner T, Yu X (2001) In vitro targeted killing of prostate tumor cells by a synthetic amoebapore helix 3 peptidemodified with two gamma-linked glutamate residues at the COOH terminus. Cancer Res 61:6783-6787
44. Werkmeister JA, Kirkpatrick A, McKenzie JA, Rivett DE (1993) The effect of sequence variations and structure on the cytolytic activity of melittin peptides. Biochim Biophys Acta 1157:50-54 (Pubitemid 23138469)
45. Zanetti M, Gennaro R, Romeo D (1995) Cathelicidins: a novel protein family with a common proregion and a variable C-terminal antimicrobial domain. FEBS Lett 374:1-5
46. Zasloff M (1987) Magainins, a class of antimicrobial peptides from Xenopus skin: Isolation, characterization of two active forms, and partial cDNA sequence of a precursor. Proc Natl Acad Sci USA 84:5449-5453
47. Zasloff M (2002) Antimicrobial peptides of multicellular organisms. Nature 415:389-395